Gene · 5648
Papers2,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander? | Front Immunol | 2022 | 36211440 | PubTator, text mining | PubMed |
| Membrane attack complexes, endothelial cell activation, and direct allorecognition. | Front Immunol | 2022 | 36211400 | PubTator, text mining | PubMed |
| Glucose metabolism and glycosylation link the gut microbiota to autoimmune diseases. | Front Immunol | 2022 | 36203617 | PubTator, text mining | PubMed |
| Comprehensive analysis of the immune and prognostic implication of MASP1 in stomach adenocarcinoma. | Eur Rev Med Pharmacol Sci | 2022 | 36196721 | PubTator, text mining | PubMed |
| SP-A binding to the SARS-CoV-2 spike protein using hybrid quantum and classical in silico modeling and molecular pruning by Quantum Approximate Optimization Algorithm (QAOA) Based MaxCut with ZDOCK. | Front Immunol | 2022 | 36189278 | PubTator, text mining | PubMed |
| Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data. | World J Gastrointest Oncol | 2022 | 36187396 | PubTator, text mining | PubMed |
| Treatment of hereditary angioedema-single or multiple pathways to the rescue. | Front Allergy | 2022 | 36172291 | PubTator, text mining | PubMed |
| Elevated risk of thrombotic manifestations of SARS-CoV-2 infection in cancer patients: A literature review. | EXCLI J | 2022 | 36172074 | PubTator, text mining | PubMed |
| The N6-methyladenosine-mediated lncRNA WEE2-AS1 promotes glioblastoma progression by stabilizing RPN2. | Theranostics | 2022 | 36168628 | PubTator, text mining | PubMed |
| MASP1 Gene Polymorphism and MASP-3 Serum Levels in Patients with Chronic Chagas Disease. | Immunol Invest | 2022 | 36166216 | PubTator, text mining | PubMed |
| Inflammatory and Proliferative Pathway Activation in Human Esophageal Myofibroblasts Treated with Acidic Bile Salts. | Int J Mol Sci | 2022 | 36142285 | PubTator, text mining | PubMed |
| Bioselectivity of silk protein-based materials and their bio-inspired applications. | Beilstein J Nanotechnol | 2022 | 36127898 | PubTator, text mining | PubMed |
| Identification of substrates of MBL Associated Serine Protease-1 (MASP-1) from human plasma using N-terminomics strategy. | Mol Immunol | 2022 | 36126499 | PubTator, text mining | PubMed |
| Single-cell analysis of gene expression in the substantia nigra pars compacta of a pesticide-induced mouse model of Parkinson's disease. | Transl Neurosci | 2022 | 36117858 | PubTator, text mining | PubMed |
| Effects of bisphenol AF on growth, behavior, histology and gene expression in marine medaka (Oryzias melastigma). | Chemosphere | 2022 | 36116629 | PubTator, text mining | PubMed |
| Deceiving and escaping complement - the evasive journey of the malaria parasite. | Trends Parasitol | 2022 | 36089499 | PubTator, text mining | PubMed |
| Nephritis-Associated Plasmin Receptor (NAPlr): An Essential Inducer of C3-Dominant Glomerular Injury and a Potential Key Diagnostic Biomarker of Infection-Related Glomerulonephritis (IRGN). | Int J Mol Sci | 2022 | 36077377 | PubTator, text mining | PubMed |
| Molecular Insights in Uterine Leiomyosarcoma: A Systematic Review. | Int J Mol Sci | 2022 | 36077127 | PubTator, text mining | PubMed |
| Hypercoagulability in COVID-19: from an unknown beginning to future therapies. | Med Pharm Rep | 2022 | 36060499 | PubTator, text mining | PubMed |
| Common and rare variants in patients with early onset drusen maculopathy. | Clin Genet | 2022 | 36053979 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5648/papers?page=20